LAPTM4B and hepatocellular carcinoma: In conclusion, our findings confirm elevated HDAC2 and LAPTM4B expression in HCC, and their association with poor clinical outcomes, supporting the hypothesis that HDAC2 promotes HCC autophagy and malignant progression by activating LAPTM4B transcription.